- Home
- SOPH vs XOMA Comparison
SOPH vs XOMA Comparison
Compare SOPH & XOMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SOPH
- XOMA
- Stock Information
- Founded
- SOPH 2011
- XOMA 1981
- Country
- SOPH Switzerland
- XOMA United States
- Employees
- SOPH N/A
- XOMA N/A
- Industry
- SOPH Biotechnology: Biological Products (No Diagnostic Substances)
- XOMA Biotechnology: Pharmaceutical Preparations
- Sector
- SOPH Health Care
- XOMA Health Care
- Exchange
- SOPH Nasdaq
- XOMA Nasdaq
- Market Cap
- SOPH 219.8M
- XOMA 330.2M
- IPO Year
- SOPH 2021
- XOMA N/A
- Fundamental
- Price
- SOPH $3.49
- XOMA $27.55
- Analyst Decision
- SOPH Buy
- XOMA Strong Buy
- Analyst Count
- SOPH 1
- XOMA 2
- Target Price
- SOPH $7.00
- XOMA $69.50
- AVG Volume (30 Days)
- SOPH 152.3K
- XOMA 87.6K
- Earning Date
- SOPH 08-05-2025
- XOMA 08-12-2025
- Dividend Yield
- SOPH N/A
- XOMA N/A
- EPS Growth
- SOPH N/A
- XOMA N/A
- EPS
- SOPH N/A
- XOMA N/A
- Revenue
- SOPH $67,173,000.00
- XOMA $42,909,000.00
- Revenue This Year
- SOPH $16.07
- XOMA $70.91
- Revenue Next Year
- SOPH $22.94
- XOMA $14.00
- P/E Ratio
- SOPH N/A
- XOMA N/A
- Revenue Growth
- SOPH 4.66
- XOMA 638.41
- 52 Week Low
- SOPH $2.58
- XOMA $18.35
- 52 Week High
- SOPH $4.92
- XOMA $35.00
- Technical
- Relative Strength Index (RSI)
- SOPH 70.98
- XOMA 59.08
- Support Level
- SOPH $2.81
- XOMA $27.08
- Resistance Level
- SOPH $3.40
- XOMA $28.70
- Average True Range (ATR)
- SOPH 0.30
- XOMA 1.22
- MACD
- SOPH 0.07
- XOMA 0.10
- Stochastic Oscillator
- SOPH 98.31
- XOMA 75.98
About SOPH SOPHiA GENETICS SA
Sophia Genetics SA is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It has built a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The Company had a physical presence in three countries outside of its headquarters in Switzerland: France, the United States, and Brazil.
About XOMA XOMA Corporation
XOMA Royalty Corp is a biotechnology royalty aggregator playing a role in helping biotech companies achieve their goal of improving human health. XOMA acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceuticals or biotechnology companies. XOMA acquires future economic rights, the seller receives non-dilutive, non-recourse funding that can use to advance their internal drug candidate(s) or for general corporate purposes. Geographically, the company operates in Switzerland, United States, Asia Pacific, Europe and Others.